A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis
Condition: Progressive Multiple SclerosisInterventions: Drug: Acyclovir; Drug: Methylprednisolone; Drug: alemtuzumab GZ402673; Drug: alemtuzumab GZ402673; Drug: Paracetamol; Drug: Loratadine; Drug: Ceterizine; Drug: DexchlorpheniramineSponsor: Genzyme, a Sanofi CompanyNot yet recruiting - verified October 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2015 Category: Research Source Type: clinical trials
Bioequivalence of Topical Acyclovir in Healthy Volunteers
Condition: Dermatologic DisordersInterventions: Drug: 5% Zovirax® cream; Drug: 5% Aciclostad cream; Drug: 5% Aciclovir cream 1A Pharma; Drug: 5% Zovirax Cold Sore Cream; Drug: 5% Zovirax® cream (Austria); Procedure: OFM; Device: OFM Probe; Device: OFM PumpSponsors: Medical University of Graz; JOANNEUM RESEARCH Forschungsgesellschaft mbHCompleted - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2015 Category: Research Source Type: clinical trials